TY - JOUR
T1 - Leiomyomatosis peritonealis disseminata with aromatase cytochrome P450 expression in a postmenopausal woman
T2 - A case study with literature review
AU - Matsuya, M. O.
AU - Sugihara, K.
AU - Yaguchi, C.
AU - Itoh, H.
AU - Kitamura, H.
AU - Kanayama, N.
AU - Arahori, K.
N1 - Publisher Copyright:
© 2018 S.O.G. CANADA Inc. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Purpose of Investigation: The authors aimed to assess the hypothesis that leiomyomatosis peritonealis disseminata (LPD) in a postmenopausal woman had autocrine estrogen secretion abilities. Materials and Methods: A 73-year-old woman presented with a bulky tumour in the peritoneal cavity. The pathological diagnosis was LPD or sarcoma of unknown origin. Medroxyprogesterone acetate (MPA) and GnRH analogue therapies were effective, but a tumour mass was confirmed with rapid growth immediately after the cessation of treatment and led to her death from intra-tumour haemorrhage. The authors evaluated the mechanism of tumour using immunostaining for aromatase cytochrome P450. Results: The tumour showed high expression of aromatase. The immunostaining patterns of estrogen receptor (ER), progesterone receptor (PgR), and aromatase were similar to those of a premenopausal leiomyoma. Conclusion: It is likely that the tumour had the autocrine ability to secrete estrogen and that tumour growth resumed because of a flare-up caused by the downregulation of hormonal therapies.
AB - Purpose of Investigation: The authors aimed to assess the hypothesis that leiomyomatosis peritonealis disseminata (LPD) in a postmenopausal woman had autocrine estrogen secretion abilities. Materials and Methods: A 73-year-old woman presented with a bulky tumour in the peritoneal cavity. The pathological diagnosis was LPD or sarcoma of unknown origin. Medroxyprogesterone acetate (MPA) and GnRH analogue therapies were effective, but a tumour mass was confirmed with rapid growth immediately after the cessation of treatment and led to her death from intra-tumour haemorrhage. The authors evaluated the mechanism of tumour using immunostaining for aromatase cytochrome P450. Results: The tumour showed high expression of aromatase. The immunostaining patterns of estrogen receptor (ER), progesterone receptor (PgR), and aromatase were similar to those of a premenopausal leiomyoma. Conclusion: It is likely that the tumour had the autocrine ability to secrete estrogen and that tumour growth resumed because of a flare-up caused by the downregulation of hormonal therapies.
UR - http://www.scopus.com/inward/record.url?scp=85053321218&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053321218&partnerID=8YFLogxK
U2 - 10.12892/ejgo4120.2018
DO - 10.12892/ejgo4120.2018
M3 - Review article
AN - SCOPUS:85053321218
SN - 0392-2936
VL - 39
SP - 838
EP - 842
JO - European Journal of Gynaecological Oncology
JF - European Journal of Gynaecological Oncology
IS - 5
ER -